-
A coalition of 19 states and the District of Columbia on Tuesday sued the Department of Health and Human Services over a declaration that could complicate access to gender-affirming care for young people.
-
The Trump administration has stated it wants the U.S. childhood vaccination schedule to look more like peer nations such as Denmark. Critics say the U.S. has different health threats.
-
Our most popular global health and development stories in 2025 covered the human impact of the upheaval in U.S. foreign aid, surprising news about familiar diseases and the beauty of earth captured by drone cameras.
-
Experts are warning that cuts at the federal level are impacting the programs that monitor food safety for consumers.
-
Scientists have developed an experimental way to study how human embryos implant in a uterus, which may provide new insights into why miscarriages occur and how they can be prevented.
-
Budget shortfalls and nearly $1 trillion in looming federal Medicaid cuts have prompted states to rein in spending on a widely embraced autism therapy, pinching families who depend on the services.
-
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
-
GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the future of this treatment method.
-
Millions of Texans could be at risk.
-
GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the future of this treatment method.
-
Without a fix from Congress, costs for many people who buy health care on the Affordable Care Act marketplace have gone up. Here's what's to know about cheaper choices — and pitfalls to be aware of.
-
Flu cases are soaring in New York and picking up in other parts of the country. Experts worry it will be another bad season. COVID and RSV have been less of a problem, but they're also on the rise.